Drach, Mathias
Papageorgiou, Karolina
Maul, Julia-Tatjana
Djamei, Vahid
Yawalkar, Nikhil
Häusermann, Peter
Anzengruber, Florian
Navarini, Alexander A.
Article History
Received: 29 April 2019
Revised: 16 June 2019
Accepted: 22 June 2019
First Online: 8 August 2019
Compliance with ethical standards
:
: Mathias Drach has no conflict of interest. Karolina Papageorgiou has no conflict of interest. Julia-Tatjana Maul is an employee of USZ and holds a “Filling the GAP” scholarship. Vahid Djamei has no conflict of interest. Nikhil Yawalkar has received honoraria for consulting and advisory board attendance from Abbvie, Almirall, Amgen, Celgene, Eli Lilly, Galderma, Gebro, Janssen, Leo, Novartis, MSD and Pfizer. Peter Häusermann has received honoraria for consulting and advisory board attendance from Abbvie, Almirall, Celgene, Eli Lilly, Galderma, Janssen, Leo and Novartis. Florian Anzengruber is an employee of the University Hospital Zurich. He has received honoraria from Abbvie, Celgene, Leo Pharma, Galderma, Eli Lilly, Almirall, Janssen—Cilag and Novartis, but has no financial interest, nor holds any shares of any pharmaceutical company. Alexander A. Navarini is on the advisory board of AbbVie, Pfizer, Novartis, Celgene, MSD, Galderma, Sanofi, Boehringer-Ingelheim, Lilly.